Free shipping worldwide | 30-Day free returns

    Item has been added

    Get 20% off!arrow_drop_up

    Bachrati 4-in-1 Skincare Efficacy Study 28-Day Clinical Evaluation - Comprehensive Report

    Study Commissioned by: Bachrati Skincare Innovations Study Oversight:

    Report Release Date:

    • March 28, 2024

    Bachrati Skincare Innovations has undertaken a dedicated 28-day clinical observation to measure and analyze the impact of the Bachrati 4-in-1 Skincare Wand coupled with the proprietary Activating Serum. The study aimed to track and evaluate the efficacy, user experience, and overall skin health improvement when using the Bachrati system. The study was segmented into two phases at intervals of Day 1, Day 14, and Day 28, offering detailed insights into the short-term and evolving benefits of the skincare regimen.

    Study Timeline:

    • Commencement Date: February 16, 2024
    • Initial Assessment: February 16, 2024
    • Midpoint Evaluation: March 1, 2024
    • Final Evaluation: March 15, 2024

    Participant Demographics:

    • Total Participants: 30 Female Volunteers
    • Age Range: 22 - 60 Years
    • Inclusive of All Skin Types: Oily, Dry, Combination, Sensitive
    • Local Distribution: Lebanese residents

    Study Adherence Rate:

    • Group A (Wand Only)
    • Group B (Wand + Serum)
    • All 30 participants completed the evaluations and shared their experiences.

     

     

    TABLE OF CONTENTS

    1. Executive Summary of the Study
    2. Allocation and Receipt of the Skincare Systems
    3. Protocol for Clinical Evaluation
    4. Ethical Considerations and Participant Confidentiality
    5. Compliance Monitoring of Participants
    6. Detailed Findings from the Clinical Evaluation

    EXECUTIVE SUMMARY

    • Total Number of Participants: 20
    • Age Demographics: 22 - 60 Years
    • Recruitment Process: Participants were selected via a rigorous screening process. They were subsequently split into two groups for a comparative analysis:
      • Group A: Interaction with the Bachrati Wand only.
      • Group B: Synergistic use of the Bachrati Wand with the Activating Serum.

    No significant adverse reactions were reported throughout the duration of the study. Some participants felt a strong current on their forehead which is due to over moisturizing before use. The goal was to comprehensively evaluate the performance of Bachrati products without bias ensuring a broad representation of skin types and conditions.


    Evaluation Metrics:
    GROUP A – BACHRATI WAND ONLY

    Section I: Product Efficacy Evaluation Participants responded on a 5-point Likert scale ranging from 'Strongly Agree' to 'Strongly Disagree' to the following statements:

    • I have observed a significant decrease in under-eye darkness.
    • I have noticed a smoothing effect on my wrinkle-prone areas.
    • Fine lines on my face have become less noticeable.
    • My skin has attained a more vibrant and glowing quality.
    • The hydration level of my skin has substantially improved.
    • My facial contours appear more defined and sculpted.
    • A rejuvenating effect on my skin is clearly visible.
    • Dark spots and discoloration on my skin have diminished.
    • The visibility of pores on my face has reduced.
    • The appearance of expression lines, particularly around the eyes, has lessened.
    • Clarity and evenness in my skin tone have improved following usage.
    • Facial puffiness has been alleviated.
    • My regular skincare products seem to work better when used in conjunction with the wand.
    • My skin’s overall appearance has improved since starting this treatment.
    • The wand has been a beneficial addition to my skincare routine.
    • There has been no irritation from using the wand.
    • I find the wand straightforward and simple to operate.
    • Using the wand has been an enjoyable aspect of my day.

    Section II: Net Promoter Score and Testimonials

    • Based on your personal experience, how likely are you to recommend the Bachrati Wand to someone you know?

    Section III: Product Packaging and Experience

    • Rate your overall experience with the product
    • Describe the aspect of the packaging you found most appealing.
    • Provide any suggestions for improvements to the packaging.

    GROUP B – BACHRATI WAND + ACTIVATING SERUM

    Section I: Combined Product Efficacy Evaluation The statements are similar to those in Group A, with additional ones specific to the serum:

    • The serum’s texture and application have contributed positively to my skincare routine.
    • I find that the serum enhances the overall effectiveness of the skincare wand.

    Section II and III: These sections mirror the structure provided for Group A but solicit feedback that includes the experience and efficacy of using both the wand and the serum together.

    Distribution of Product: Participants in Group A were provided with the Bachrati Skincare Wand alongside comprehensive usage instructions. Group B participants received a month's supply of Bachrati’s Activating Serum in addition to the Skincare Wand.

    Study Protocol: The protocols outlined below were adhered to by the study participants throughout the duration of the trial.

    GROUP A: Inclusion: Bachrati Skincare Wand

    Usage Instructions: Participants were advised to begin their regimen with the Skincare Wand for 5 minutes daily, increasing the duration gradually as tolerated, not to exceed 30 minutes per session.

    Application:

    • Start with a clean and dry face.
    • For enhanced results, apply the wand to hydrated skin, using Bachrati’s Activating Serum or any preferred skincare product to maintain moisture during treatment.
    • Activate the device by simply placing it against the skin, moving it in an upward and outward motion.
    • Reference the provided digital tutorials for a comprehensive understanding of product use.

    Product Cautions:

    • The Bachrati Skincare Wand is strictly for cosmetic use and not intended for those with significant health conditions.
    • The product should be kept out of children’s reach.
    • It is not recommended for individuals with certain medical conditions (e.g., cancer, pacemakers, pregnancy).

    Survey Schedule: Participants received surveys via email on Day 0, Day 13, and Day 27, with expectations to respond by the end of Day 1, Day 14, and Day 28.

    Adverse Events: Any negative reactions should prompt immediate discontinuation of use and contact with the study coordinators.

    GROUP B: Includes all elements from Group A with the addition of the Activating Serum.

    Usage Instructions:

    • Apply a generous amount of Activating Serum before using the Skincare Wand.
    • Reapply serum as needed to maintain glide and hydration during the session.

    The rest of the protocols are consistent with Group A.

    Participant Consent and Privacy: The purpose of the study was to collate user feedback on the Bachrati products, ensuring the confidentiality of personal data at all times.

    Participants consented to the study’s terms, and data collection was executed with strict adherence to privacy regulations, preserving participant anonymity.

    Participant Agreement: Each participant agreed to:

    • Utilize and evaluate the products as per instructions.
    • Complete all required surveys.
    • Submit one testimonial detailing their experience.

    Incentives: Participants received the Bachrati products free of charge and were offered a study completion incentive.

    Consents: Participants consented to the collection and usage of data by Bachrati for the improvement and promotion of its products.

    Privacy Assurance: Bachrati committed to protecting personal information and ensuring no association of data with identifiable information in any promotional material.

    Liability and Warranty Disclaimer: Bachrati made no express warranties regarding the outcomes and disclaimed all liability for indirect damages.

    Participant Compliance: The study maintained a full completion rate with no adverse effects causing discontinuation.

     

    Survey results: